Lanean...
Coming together at the hinges: Therapeutic prospects of IgG3
The human IgG3 subclass is conspicuously absent among the formats for approved monoclonal antibody therapies and Fc fusion protein biologics. Concern about the potential for rapid degradation, reduced plasma half-life, and increased immunogenicity due to marked variation in allotypes has apparently...
Gorde:
| Argitaratua izan da: | MAbs |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7899677/ https://ncbi.nlm.nih.gov/pubmed/33602056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2021.1882028 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|